Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Withdrawn 1Unknown 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 2Lymphoid 2Other 1Myeloid 1Gynecologic 1Classical hematology 1

Conditions

Leukemia, Myeloid, Acute 3510Precursor Cell Lymphoblastic Leukemia-Lymphoma 2499Leukemia 2362Leukemia, Lymphocytic, Chronic, B-Cell 1992Myelodysplastic Syndromes 1412Hematologic Neoplasms 1385Lymphoma 1176Lymphoma, Non-Hodgkin 1079Leukemia, Myelogenous, Chronic, BCR-ABL Positive 863Lymphoma, Follicular 761Multiple Myeloma 739Lymphoma, Mantle-Cell 730Lymphoma, Large B-Cell, Diffuse 714Burkitt Lymphoma 692Lymphoma, B-Cell, Marginal Zone 645Hodgkin Disease 636Recurrence 627Leukemia, Myelomonocytic, Chronic 536Neoplasms 519Lymphoma, Large-Cell, Immunoblastic 451Myeloproliferative Disorders 445Leukemia, Myeloid, Chronic-Phase 437Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 414Congenital Abnormalities 411Waldenstrom Macroglobulinemia 360Blast Crisis 353Leukemia, Myeloid, Accelerated Phase 318Lymphoma, T-Cell, Cutaneous 311Primary Myelofibrosis 297Neoplasms, Plasma Cell 276

Interventions

Rituximab 1Brentuximab Vedotin 1Bendamustine Hydrochloride 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Infectious Mononucleosis × Other hematologic neoplasm × Clear all
NCT05473325 2022-08-15

BRANCH-P

Willows Health

Unknown
2,000 enrolled
OtherOther hematologic neoplasm

Acquired Immunodeficiency Syndrome, Alzheimer Disease, Appendicitis, Arthritis, Bronchitis, Bulimia, Cardiovascular Diseases, Cellulitis, Depression, Diabetes Mellitus, Dyspepsia, Eczema, Fibrosis, Gout, Heart Diseases, Hypercholesterolemia, Hypersensitivity, Infections, Infectious Mononucleosis, Influenza, Human, Intestinal Diseases, Leukemia, Liver Diseases, Alcoholic, Neoplasms, Obesity, Osteoporosis, HIV Infections, Renal Insufficiency, Chronic

NCT04138875 2022-06-23

A Risk Stratified Sequential Treatment With Rituximab, Brentuximab Vedotin and Bendamustine (RBvB)

Yale University

Phase 2 Withdrawn
Other hematologic neoplasm

Infectious Mononucleosis, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡